Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Visiopharm and Hamamatsu Announce Worldwide OEM Agreement

Published: Monday, July 09, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
Reseller partnership for quantitative digital pathology.

Visiopharm and Hamamatsu have announced a non-exclusive worldwide original equipment manufacturer (OEM) agreement and reseller partnership for Visiopharm’s Quantitative Digital Pathology (QDP) solutions.

Under the partnership, Visiopharm will be an OEM for Hamamatsu’s new NDP.analyze software, a research tool for tissue image analysis, which is fully compatible with Visiopharm’s entire suite of QDP solutions.

Hamamatsu will market and sell the entire suite of QDP solutions, including CloudAnalysis, DeployedAnalysis, Stereology, and Application Protocol Packages (APPs) from Visiopharm’s new APPCenter.

NDP.analyze will be exhibited at Analytica 2012, 17th to 20th April 2012, in Munich, Germany.

Hamamatsu, who is known throughout the world for their NanoZoomer Digital Pathology (NDP) whole slide scanners, will expand their offering in digital pathology to include quantitative digital pathology.

The full range of analysis solutions are integrated with the NDP.serve data management software. The software will be available directly from Hamamatsu worldwide.

Masafumi Oshiro, Product Manager of Hamamatsu Photonics, stated “Hamamatsu is committed to provide complete solutions of high quality to its customers. Image analysis is becoming an increasingly important part of Digital Pathology. With the NDP.analyze and the software from Visiopharm fully integrated in the NDP environment, we are now able to provide a powerful image analysis solution. This powerful solution scales across the needs from individual academic researchers to large pharmaceutical companies with a regular and high-volume need for analysis. We are pleased to be able to offer image analysis APPs that provide a risk-free approach to image analysis for our customers and at the same time, provide immediate productivity with a very low learning curve.

NDP.analyze integrated with Visiopharm’s innovative solutions for QDP, will provide Hamamatsu customers with leading technology and flexible options, including analysis of NanoZoomer whole slide images in the Cloud and unlimited access to Visiopharm’s patent-pending APPCenter.

The APPCenter will provide both new and existing NanoZoomer and Visiopharm customers with innovative, affordable options for their deployed solutions, but also allow them to expand their efforts to collaborate and share data in the Cloud.

CloudAnalysis is an easy to budget solution for Hamamatsu customers who need access to sophisticated image analysis capabilities for a specific project which is limited in time.

Whether it is for a week, a month or longer, customers will only pay for analysis when they need it. Hamamatsu customers can now have instant access, and will be able to analyze whole slide images from work, home, or from anywhere.

Michael Grunkin PhD, CEO of Visiopharm, stated “We are very impressed with Hamamatsu and their innovative vision for digital pathology. The NanoZoomer is a very robust product capable of providing scanned images of a consistent high quality and with a very competitive scan speed. It is clear to us that Hamamatsu will play an important role in providing integrated and complete quality solutions to the research market. An OEM agreement and reseller partnership with Hamamatsu will expand the availability of Visiopharm’s QDP solutions worldwide, and enable the rapidly growing digital pathology market to work in an efficient, integrated digital workflow with Hamamatsu’s NanoZoomer Digital Pathology solutions.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
An Innovative Algorithm to Decipher How Drugs Work Inside the Body
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
How do Networks Shape the Spread of Disease and Gossip?
A team of mathematicians from Oxford University, University of North Carolina at Chapel Hill, and Rutgers University used a set of mathematical rules to encode how a contagion spreads, and then studied the outcomes of these rules.
AncestryDNA and Calico to Research the Genetics of Human Lifespan
Collaboration will analyze family history and genetics to facilitate development of cutting-edge therapeutics.
Informatics Tool Helps Scientists Prioritize Protein Modification Research
Researchers have developed a new informatics technology that analyzes existing data repositories of protein modifications and 3D protein structures to help scientists identify and target research on "hotspots" most likely to be important for biological function.
Software Differences can Skew Medical Scan Results
Differences in software can significantly skew results of medical scans commonly used in clinical care and research.
AMRI, PerkinElmer to Collaborate on Drug Discovery
Albany Molecular Research (AMRI) and PerkinElmer are collaborating to provide drug discovery infrastructure and services in AMRI's newly launched drug discovery center.
Exploring Living cells
JPK reports the exploration of living cells using nanoscale and single molecule techniques through the application of scanning probe microscopy.
Vulnerabilities in Genome's 'Dimmer Switches' Should Shed Light on Hundreds of Complex Diseases
Up to one-fifth of human DNA act as dimmer switches for nearby genes, but scientists have long been unable to identify precisely which mutations in these genetic control regions really matter in causing common diseases.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!